Subtyping of triple-negative breast cancer: implications for therapy.

Abramson VG, Lehmann BD, Ballinger TJ, Pietenpol JA
Cancer. 2015 121 (1): 8-16

PMID: 25043972 · PMCID: PMC4270831 · DOI:10.1002/cncr.28914

MeSH Terms (7)

Antineoplastic Agents Clinical Trials as Topic Female Gene Expression Regulation, Neoplastic Humans Molecular Targeted Therapy Triple Negative Breast Neoplasms

Connections (3)

This publication is referenced by other Labnodes entities:

Links